Navigation Links
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Date:7/1/2008

l trials and obtaining a premarket approval, or PMA, from the FDA. The PMA process requires Echo to prove the safety and efficacy of its tCGM system to the FDA's satisfaction. This process can be expensive and uncertain, and there is no guarantee that Echo will be able to submit a PMA for its Symphony tCGM System or that its Symphony tCGM System will be approved by the FDA in any specific timeframe or at all. In addition, clinical testing of Echo's products and eventual commercialization of its products are subject to all of the risks and uncertainties set forth in its periodic reports filed with the Securities and Exchange Commission.

These and other factors are identified and described in more detail in Echo's filings with the Securities and Exchange Commission, including, without limitation, its annual report on Form 10-KSB for the year ended December 31, 2007, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. The foregoing list of factors is not exhaustive. Echo Therapeutics, Inc. undertakes no obligation to publicly update or revise any forward-looking statements.

For More Information:

Patrick T. Mooney, M.D. Lilian Stern

Chairman and Chief Executive Officer Stern Investor Relations

(856) 429-8778 (212) 362-1200


'/>"/>
SOURCE Echo Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Silence Therapeutics Announces Board Changes
2. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
3. Data Presented at American Headache Societys Annual Scientific Meeting Show Primary Endpoint Met as Well as Improvement on Important Secondary Endpoints in Phase IIb Acute Migraine Trial of TorreyPines Therapeutics Tezampanel
4. TorreyPines Therapeutics to Host Webinar at 11 a.m. EDT Today on the Opportunity for Treating Chronic Pain, Migraine and Muscle Spasticity Through Inhibition of Neurotransmitter Glutamate
5. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
6. Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health
7. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
8. PTC Therapeutics Announces Data from Additional Clinical Studies of PTC124 in Cystic Fibrosis Confirming Activity
9. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: ... that specializes in developing safer, more effective cannabis-based ... C. Anderson , Ph.D., to its Scientific Advisory ... who brings significant drug discovery and development expertise ... synthetic organic chemist by training with more than ...
(Date:3/31/2015)... 31, 2015  CVS Health (NYSE: CVS ... clinical affiliations with Rush University Medical Center in ... Medical Center in Tucson, Arizona ... Care. These affiliations will help enhance access to ... these clinical affiliations, CVS Health will provide prescription ...
(Date:3/31/2015)... 31, 2015 Biorasi , a ... strategic partnership with Medidata , the leading ... in life sciences. Offering therapeutic expertise in a ... Medidata,s electronic data capture (EDC), management and reporting ... through IV global clinical trial business. ...
Breaking Medicine Technology:InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4
... First Disease Database for the ... VentriPoint Diagnostic System, SEATTLE, ... (KBR) enables accurate three,dimensional reconstruction of right ventricular volume and ... time and for,a lower cost than currently applied methods., ...
... mid 2008 with Phase 2 development ... begin late in 2008 or in early 2009 -, SAN ... announced positive results from the Phase 1,proof-of-concept trial (n=30) of NU172, ... single bolus dose with a favorable safety profile., "There is ...
Cached Medicine Technology:Knowledge Based Reconstruction Demonstrates Accuracy in Obtaining Ventricular Volume and Function in Tetralogy of Fallot Patients, According to VentriPoint Diagnostics 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 3Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 4
(Date:3/31/2015)... GA (PRWEB) March 31, 2015 When SIGVARIS ... the company’s most successful product launch to date. Women immediately ... SIGVARIS is giving women another reason to love EVERSHEER with ... time for spring. , Lavender mist pairs perfectly with ... and neutral outfits. For women looking to add a hint ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 India ... Insurance programs, issues a travel advisory to all USA ... costs in the United States are higher than many ... in developed countries. For example, a coronary artery ... same procedure costs about $34,358 . Visitors are ...
(Date:3/31/2015)... March 31, 2015 DentalXChange, ... specializes in providing online solutions to connect ... it has achieved full accreditation for the ... Accreditation Program (HNAP) from the Electronic Healthcare ... HNAP accreditation runs in two-year increments and ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 A' Design ... design project Bruker EVOQ by Daniel Dion has been ... Award in Scientific Instruments, Medical Devices and Research ... Daniel Dion, the creative mind behind the award winning ... MS - developed under the direction of Dr. Rohan ...
(Date:3/31/2015)... A team of Italian scientists is ... properties, into mesothelioma cancer cells. Surviving Mesothelioma has just ... website. Click here to read it now. ... to the spice turmeric, has limited value as a ... at Università di Napoli Federico II are getting around ...
Breaking Medicine News(10 mins):Health News:Put Spring in Your Step with SIGVARIS’ Top Selling Sheer Hosiery Compression Therapy Brand 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 2Health News:India Network Foundation issues travel advisory to all US bound travelers on visitor health insurance requirements 3Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 2Health News:DentalXChange Achieves EHNAC Healthcare Network Accreditation for Fifth Consecutive Time 3Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2
... today formally inducted 11 private healthcare providers into the public ... in the health sector. //Mr Blair and the health secretary, ... at Downing Street to mark the launch of NHS Partners ... work as partners towards 'future success' of the NHS. "Wherever ...
... are at a lesser risk of Parkinson’s, according to ... and Psychiatry. // ,The research team, as ... patients and 106 healthy people, belonging to the same ... sought to throw light on their personality traits and ...
... much as 140 million valuable lives, based on reports ... the report, internationally renowned economic modeller Warwick McKibbin and ... even a mild pandemic could kill 1.4 million people ... production. ,The report warned that developing effective ...
... millionaire currently living in Australia claims to have discovered ... worst form of attention deficit hyperactivity disorder (ADHD). //This ... astronauts returning from space. But it can also be ... rebalancing their brains. , ,Attention deficit hyperactivity disorder ...
... Electronics has said that it will start to roll out ... from using an enzyme contained in the "the pungent national ... dreaded bird flu virus. ,"We developed the filter ... spokeswoman Park Se-won said. The filter was fabricated after assessing ...
... against a Wall, to cough up more on Healthcare for its ... doing this for the cause of the workers, and improve their ... The scene is on the brink of a major tussle between ... scene at Washington is hotting up with the battle lines clearly ...
Cached Medicine News:
... KR-9000PW Wavefront Analyzer provides the practitioner ... visual analysis system on the market ... range auto refractometer, auto keratometer, and ... the benefits of wavefront measurement!, ,The ...
... The Worlds First Combination Unit, the ... Refractor, Keratometer, and Non-Contact Tonometer. By combining ... allows you to save time while providing ... trust from Marco. The M3 not only ...
... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
Medicine Products: